


| Clearside Biomedical Announces License Agreement with Arctic Vision for XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) in Greater China and South Korea |
|
– Arctic Vision to Lead Expansion of Novel Approach to Treating Macular Edema Associated with Uveitis in Asia – – Clearside Eligible to Receive Upfront and Milestone Payments and Royalties on Product Sales – – Increasing Global Awareness of Innovative Suprachoroidal Injection Platform – ALPHARETTA, Ga.
Posted: 2020-03-11 21:37:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.